Bacterial infections of the ears, nose, throat, chest, lungs, teeth, skin, and urinary system can be treated with Cavmox CV oral suspension. Beta-lactamase is an enzyme produced by the bacteria that cause multidrug-resistant (MDR) TB. The antibiotics are broken down and rendered useless by this enzyme. Consequently, the bacteria develop resistance to the antibiotic being administered. Amoxycillin and clavulanic acid are the two active components in Cavmox CV Oral Suspension. Amoxycillin works to kill the bacteria that causes tuberculosis, but clavulanic acid prevents the enzyme from making it ineffective. This makes the combination of amoxycillin and clavulanic acid an effective treatment for resistant tuberculosis.